The early innate response after Mycobacterium bovis BCG vaccination is poorly characterized, but probably decisive for subsequent protective immunity against tuberculosis. Therefore, we vaccinated mice with fluorescent BCG strains in the ear dorsum, as a surrogate of intradermal vaccination in humans. During the first three days, we tracked BCG host cells migrating out of the dermis to the auricular draining lymph nodes (ADLN). Resident skin dendritic cells (DCs) or macrophages did not play a predominant role in early BCG capture and transport to ADLN. The main BCG host cells rapidly recruited both in the dermis and ADLN were neutrophils.
Introduction
Mycobacterium bovis BCG is the only available vaccine against tuberculosis (TB), a major public health problem. Being included in the WHO Expanded Program for Immunization, BCG is one of the most widely administered vaccines. It confers high levels of protection against disseminated forms of TB, particularly severe in children, but its efficacy against pulmonary TB in adults is estimated to be only 50 percent 1 and varies widely between different geographic areas and populations. Thus more efficient vaccines against TB are urgently needed. There are reasons to believe that such vaccines could be based on BCG. Therefore, a better understanding of the immune response induced by BCG could help to design better strategies on a rational basis. Today, BCG vaccination is almost exclusively administered intradermally or percutaneously 2 . Early events taking place after BCG vaccination that will strongly impact on the adaptive immune response are poorly characterized. For example, it is unknown how BCG travels from the injection site to draining lymph nodes (DLN) and which host cells could be involved in this early process. Mononuclear phagocytes such as epidermal Langerhans cells (LCs), dermal macrophages and DCs are ideally located to capture microorganisms entering skin.
Due to their migratory capacity, DCs shuttle pathogens such as HIV 3 or Leishmania major 4 to DLN. Bacterial dissemination from gut to mesenteric DLN occurs via infected DCs after ingestion of Salmonella 5 or Listeria 6 . Peripheral tissue DCs are not the only cells at play in bridging innate and acquired immunity to pathogens. Soon after an inflammatory stimulus, blood monocytes are recruited to the injured tissue from which they can migrate via afferent lymph towards DLN. There, monocytes acquire a DC phenotype 7 and prime the T-cell response 8 .
During systemic infection with Listeria monocytogenes, blood monocytes are able to shuttle bacteria into the brain 9 . Thus, it is also plausible that inflammatory monocytes could transport pathogens from peripheral tissue to DLN, although recent work suggests that, after Salmonella typhimurium injection into the skin, local inflammation impairs their migration and conversion to DCs in the DLN 10 .
Given the decisive impact of innate events taking place after BCG vaccination on the ensuing adaptive immune response, we decided to analyze them in mice injected into a strictly dermal site, the ear dorsum. Taking advantage of a fluorescent rBCG-egfp strain, cells carrying BCG were characterized from skin explants and auricular DLN (ADLN) at early time-points after BCG vaccination. Contrary to our expectations, resident skin mononuclear phagocytes did not play a predominant role in BCG capture and transport to secondary lymphoid organs. We observed that neutrophils, that were the first cells recruited into the ear dermis and captured BCG, also massively infiltrated the ADLN where they represented the main primary host cells for BCG.
Neutrophils carrying fluorescent bacilli were detected inside skin lymphatic vessels. Upon BCG vaccination, green or red fluorescent labelled neutrophils injected into left or right ear migrated exclusively to the ipsilateral DLN. Together our data support the concept that neutrophils leave an inflamed site via afferent lymphatics, migrate to the secondary lymphoid organ and participate in the transport of live microorganisms.
Materials and methods

Animals
Female 6-12 weeks C57BL/6 mice (Centre d'Elevage Janvier, Le Gesnet-Saint-L'Isle, France)
were housed in our animal care facility under specific pathogen free conditions. 
Bacterial strain, immunizations and CFU determination
Skin explant cultures and preparation of ADLN cell suspensions
At different time points after BCG-egfp injection into the ear dorsum, mice were euthanized and ears were surgically removed. Control mice inoculated with 10 µl of Beck medium were processed the same way. Dorsal and ventral halves were split and layered on RPMI 1640
supplemented with 10% FCS (Dominique Dutscher, Brumath, France), HEPES (100 mM) and penicillin (100 µg/ml). After 24 h at 37°C, ear skin explant migrating cells from eight mice were pooled and filtered through a 70 µm nylon mesh before antibody staining. ADLN cells were dissociated from the matrix by a 25 min incubation at 37°C with 1 mg/ml collagenase D and 40 µg/ml DNAseI (Roche-Diagnostics, Mannheim, Germany) in RPMI. 
Results
Intradermal inoculation of BCG in mouse ear rapidly leads to bacilli tranfer to ADLN
In order to study cell migration that take place early after intradermal BCG vaccination, we have used a model of BCG inoculation in mouse ear, a site allowing injection strictly into the dermis and excluding the involvement of subcutaneous connective tissue 16 . We first quantified bacterial multiplication in the ear and the ADLN after vaccination with 10 6 CFUs of BCG ( Figure 1 ). The majority of the injected BCG was recovered from the ears at 4 hours post injection (hpi) and the bacterial load only slightly declined over the next 7 days. At 14 days after injection, a more important reduction of the bacterial load was observed in the ear, probably corresponding to the onset of the adaptive immune response. In the ADLN, approximately 1% of the injected bacilli (10 4 CFUs) were recovered as soon as 4 hpi and this BCG load was stably maintained over the next 14 days. Thus, the model of BCG intradermal inoculation in C57/BL6 mouse ear leads to rapid tranfer of live bacilli into the ADLN where they can persist for at least two weeks.
DCs are minimally associated with BCG at the vaccination site and in the ADLN
In vivo, LCs from the epidermis and DCs from the dermis migrate to the DLN very shortly upon inflammatory stimulation. This situation can be mimicked in vitro by the skin explant culture method where cells migrating out of skin can be analyzed after 24 hours incubation in medium 17 .
In order to track BCG-infected DCs crawling out of skin, we performed ear skin explant cultures from 4 to 72 hours after auricular injection of BCG-egfp. Throughout the kinetics, 19 to 48% from all skin explant cells were EGFP + i.e. BCG-infected ( Figure 2A ). Among them, remarkably low numbers -at most 3% -stained positive for CD11c, the most widely distributed mouse DC marker indicating that rare emigrant DCs carried BCG. In accordance, BCG was generally not associated with CD11c + DCs in the dermis as observed after immunofluorescence on ear skin sections ( Figure 2B ). We also analyzed LCs and BCG association by means of anti-CD207
(Langerin) antibody 929F3 14 . At 12 and 72 hpi between 19 and 5 % of the total skin explants emigrant CD11c + cells were identified as LCs. Among all skin emigrant LCs, a maximum of 4%
carried BCG and no Langerin-BCG colocalization could be observed in ear skin sections (Supplemental Figure S1 ). Thus, although rare skin emigrant DCs carrying BCG could be observed by flow cytometry, they accounted for a minor proportion of total BCG-host cells.
We next stained ear sections with ER-MP23, an antibody directed against mMGL1/2 (murine macrophage galactose/N-acetylgalactosamine-specific C-type lectin/DC asialoglycoprotein receptor) a receptor largely distributed on mononuclear phagocytes that populate mouse skin 18 .
At 4 hpi or 72 hpi, we rarely detected ER-MP23 + cells carrying BCG ( Figure 2B ). Taken together, our data indicate that resident skin mononuclear phagocytes, including LCs, dermal DCs and macrophages, are not main cells for early BCG uptake at the vaccination site.
As BCG transfer from the injection site to the ADLN was found to occur rapidly, we assessed whether BCG-loaded DCs could be detected in the ADLN. Thus, we analyzed CD11c To confirm that BCG-infected neutrophils can enter skin lymphatics to migrate to the ADLN, ear cryosections were labeled four hours after BCG injection with antibody against Lyve-1, a molecule specifically expressed in lymphatic endothelium 15 . After hematoxylin counter-staining we observed that, close to the injection site, neutrophils characterized by their polylobed nucleus, were present in the lymphatic vessel lumen ( Figure 6B ). Phenotype and localization of such neutrophils was further confirmed by anti-Ly-6G and anti-Lyve-1 costaining ( Figure 6B ). After removing the epidermis, we stained the dermis with anti-Lyve-1 to observe longitudinal lymphatic vessels by confocal microscopy. Neutrophils, surface-stained with anti Ly-6G, were detected inside the lumen of lymphatics and contained intracellular BCG (EGFP + ) ( Figure 6C ).
Thus, BCG-infected neutrophils were observed inside skin lymphatic vessels in the injection site vicinity confirming their capacity to shuttle live bacilli from skin to ADLN.
Fluorescent-labeled neutrophils injected into the ear accumulate in ipslateral ADLN after BCG administration
The migratory capacity of tissue resident DCs has been largely described. More recently, monocytes recruited to tissues upon inflammation have been shown to retro-transmigrate to the or Leishmania major 22 , from the injection site to the DLN has recently been ruled out. Only on occasions, between 4 and 72 hpi, did we detect conventional CD11c + DCs carrying BCG in ADLN. Skin-derived DCs that reside in cutaneous LN are the first to acquire lymph-borne antigens inoculated into the mouse dermis 23 . Because BCG-loaded DCs, in the dermis or crawling out of skin explants, were barely observed at these time-points, we favor the idea that the rare early BCG-infected DCs in ADLN had captured live bacilli in situ rather than in the periphery. However, since BCG persisted in skin for at least 14 days, we do not rule out that resident DCs transported BCG to regional DLN after the first three days following inoculation, during later migration waves. Inflammatory blood-borne monocytes are able to shuttle Listeria into the brain. As these cells can also retro-transmigrate from tissue to LN via afferent lymph 7, 8 , they were also likely candidates to shuttle BCG to regional DLN. Nevertheless, in our model where a strong influx of neutrophils was induced, infected mononuclear cells were not observed at early time points in ADLN. Interestingly, Rotta et al. recently reported that local inflammation induced by Salmonella typhimurium injected into the skin blocked inflammatory monocyte migration and conversion into DCs in the DLN 10 .
In humans, BCG reported side-effects include local cutaneous lesions and regional suppurative lymphadenitis 24 , and BCG vaccination often develops as local ulcer leaving a characteristic scar [25] [26] [27] [28] . We found that neutrophils were recruited to the skin within four hours after intradermal BCG injection and colocalized with bacilli which they efficiently phagocytosed. However, invariably high numbers of bacteria could be grown from the dermis for at least 14 days showing that neutrophils did not efficiently clear BCG in skin. This is consistent with a report that mouse blood neutrophils efficiently phagocytose BCG but that the oxidative burst, essential for killing, is impaired 27 .
During the first three days, neutrophils remained mainly concentrated at the injection site where they focused around BCG. Later after injection, macrophages were localized close to neutrophils suggesting a granuloma-like formation (data not shown). It was recently shown that neutrophils play an essential role in the early granulomatous response in the lung after TB infection in mice 29 . Our study suggests a role for neutrophils in the establishment of this immune cell structure after BCG vaccination as well, although its precise contribution is unknown.
Neutrophils are considered as end-stage inflammatory cells, rapidly recruited to inflammatory sites to fight against microbial infection. There, they are assumed to rapidly die before phagocytosis by resident macrophages. Thus, we were surprised to observe that neutrophils were also the main early BCG host cells in the ADLN. As soon as four hours post-injection, neutrophils colocalized with BCG in the subcapsular space indicating that they had reached the lymphoid tissue via afferent lymph. By using two different fluorescent BCG strains, we observed that neutrophils reaching the ADLN were mainly, although not exclusively, loaded with one color indicating that they had phagocytosed BCG in the periphery. Strikingly, using antibody directed against Lyve-1, a molecule only expressed in lymphatic endothelium 15 , we could observe BCG-infected neutrophils in skin lymphatic vessel lumen only a few hours after BCG vaccination thus confirming the migration of infected neutrophils from periphery to the secondary lymphoid organ via afferent lymphatics. So far, such a role in microorganism transport has only been documented for DCs 4, 20 and inflammatory monocytes 9 . We report here that neutrophils may also play such a role. Nevertheless, our data do not exclude that bacilli also enter 
